NEWARK, DE/— The global oral controlled release drug delivery technology market is poised for substantial growth, projected to expand from USD 45.13 billion in 2026 to USD 90.45 billion by 2036, registering a CAGR of 7.20% during the forecast period, according to Future Market Insights (FMI). The market is witnessing accelerated demand due to the increasing prevalence of chronic diseases, growing need for patient-friendly dosage regimens, and advancements in pharmaceutical...

NEWARK, DE /— The global inhalation contract development and manufacturing organization (CDMO) market is poised for significant growth, projected to expand from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, registering a CAGR of 5.7% during the forecast period. This growth is being fueled by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and rising demand for outsourced pharmaceutical...

The global targeted oncology biologics market is poised for robust expansion, projected to grow from USD 74,751.0 million in 2026 to USD 186,948.7 million by 2036, registering a CAGR of 9.6% over the forecast period, according to Future Market Insights (FMI). This growth is driven by the structural shift in oncology care toward molecularly defined treatment pathways, where therapies are tailored based on tumor biology rather than conventional cytotoxic approaches. The market is...

The global cytotoxic chemotherapy market is projected to expand steadily from USD 24,628.0 million in 2026 to USD 39,358.0 million by 2036, registering a CAGR of 4.8% over the forecast period, according to Future Market Insights (FMI). Growth remains anchored in the continued reliance on cytotoxic agents as core components of cancer treatment regimens across solid tumors and hematological malignancies. Despite rapid advancements in targeted therapies and immuno-oncology, cytotoxic...

The global medical sharps market is poised for rapid expansion, projected to grow from USD 10.9 billion in 2026 to USD 45.3 billion by 2036, registering a robust CAGR of 15.3% over the forecast period, according to Future Market Insights (FMI). Growth is being driven by rising injection volumes, expanding vaccination programs, and stringent enforcement of occupational safety regulations across healthcare systems. The market is witnessing a strong shift toward safety-engineered...

The global IV bag and tubing recycling market is poised for significant expansion, projected to grow from USD 883.0 million in 2026 to USD 3,050.7 million by 2036, registering a robust CAGR of 13.2% over the forecast period, according to Future Market Insights (FMI). Growth is being driven by rising volumes of single-use medical plastics, increasing regulatory pressure, and the need for cost-efficient, compliant waste management systems across healthcare facilities. Healthcare...

The global disease-modifying MS therapies market is poised for sustained growth, projected to expand from USD 31,915.8 million in 2026 to USD 63,372.5 million by 2036, registering a CAGR of 7.1% over the forecast period, according to Future Market Insights (FMI). Growth is being driven by a structural shift toward long-term disease modification, earlier treatment initiation, and sustained therapy usage in multiple sclerosis (MS) management. The market reflects a transition from...

NEWARK, DE /— The global radiotherapy patient positioning accessories market is projected to witness steady growth, expanding from USD 680.3 million in 2025 to USD 1,026.6 million by 2035, registering a CAGR of 4.2% over the forecast period, according to Future Market Insights (FMI). Growth is being driven by the rising emphasis on precision in radiation therapy, increasing cancer incidence, and the adoption of advanced radiotherapy technologies worldwide. The market...

NEWARK, DE/— The global hospital-at-home equipment rental market is witnessing strong momentum, projected to grow from USD 1.6 billion in 2026 to USD 3.8 billion by 2036, registering a CAGR of 9.4% during the forecast period, according to Future Market Insights (FMI). Growth is being driven by the rapid transition of acute and post-acute care from hospitals to residential settings, supported by evolving reimbursement frameworks and increasing healthcare system pressures. The market...

NEWARK, DE — The global CCR6 antagonists market is entering a high-growth phase, expanding from USD 1.0 billion in 2026 to USD 4.0 billion by 2036, registering a CAGR of 12.0%, according to Future Market Insights (FMI). Growth is being driven by increasing adoption of targeted immunotherapies, rising prevalence of autoimmune and inflammatory diseases, and expanding clinical trial pipelines focused on precision medicine approaches. CCR6 antagonists are emerging as next-generation...

Saudi Arabia’s Pharmaceutical Industry to Reach USD 17.7 Billion by 2035, Fueled by Prescription Drug Demand and Healthcare Expansion NEWARK, DE — The pharmaceutical industry in Saudi Arabia is poised for steady growth, expected to increase from USD 10.6 billion in 2025 to USD 17.7 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.2%, according to Future Market Insights (FMI). The sector’s expansion is driven by rising healthcare expenditure,...

NEWARK, DE — The global gastroesophageal reflux disease (GERD) device market is witnessing steady growth, expected to expand from USD 1.3 billion in 2026 to USD 2.0 billion by 2036, registering a CAGR of 3.9%, according to Future Market Insights (FMI). Market expansion is being driven by rising prevalence of digestive disorders, increasing obesity rates, and growing adoption of minimally invasive diagnostic and treatment technologies in gastroenterology. GERD...